Standardized Outcomes in Nephrology-Glomerular Disease (SONG-GD): establishing a core outcome set for trials in patients with glomerular disease

Affiliations

• ¹ Sydney School of Public Health, The University of Sydney, Sydney, Australia; Centre for Kidney Research, The Children's Hospital at Westmead, Sydney, Australia. Electronic address: simon.carter@health.nsw.gov.au.
• ² Faculty of Medicine, Centre for Inflammatory Disease, Imperial College London, London, UK.
• ³ Faculty of Medicine, University of Toronto, Toronto, Canada; Toronto General Research Institute, Toronto, Canada.
• ⁴ Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India.
• ⁵ Department of Medicine, Division of Nephrology, University of British Columbia, Vancouver, Canada.
• ⁶ Department of Infection, Immunity and Inflammation, University of Leicester, Leicester, UK; John Walls Renal Unit, Leicester General Hospital, Leicester, UK.
• ⁷ Nephrology Department and Renal Transplantation Unit, Laiko Hospital, Athens, Greece.
• ⁸ Division of Nephrology, University of Louisville, Louisville, Kentucky, USA.
• ⁹ Fondazione Ricerca Molinette, Regina Margherita Hospital, Turin, Italy.
• ¹⁰ Department of Internal Medicine, Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, USA.
• ¹¹ Department of Nephrology and Clinical Immunology, RWTH University Hospital, Aachen, Germany.
• ¹² Faculty of Medicine, University of Toronto, Toronto, Canada; Sunnybrook Health Sciences Centre, Toronto, Canada.
• ¹³ Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA; Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
• ¹⁴ Department of Nephrology, Monash Health, Victoria, Australia; Centre for Inflammatory Diseases, Monash University Department of Medicine, Victoria, Australia.
• ¹⁵ Stanford University Medical Center, Stanford, California, USA; Department of Medicine, Division of Nephrology, Stanford University, Stanford, California, USA.
• ¹⁶ Nephrology Department, Hospital Fernández, Buenos Aires, Argentina.
• ¹⁷ Columbia University Medical Center, New York, New York, USA; Division of Nephrology, New York Presbyterian Hospital, New York, New York, USA.
• ¹⁸ Department of Internal Medicine, Division of Nephrology, Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
• ¹⁹ Renal Division of Peking University First Hospital, Beijing, China.
• ²⁰ Sydney School of Public Health, The University of Sydney, Sydney, Australia; Centre for Kidney Research, The Children's Hospital at Westmead, Sydney, Australia.
• ²¹ Centre for Kidney Research, The Children's Hospital at Westmead, Sydney, Australia.
• ²² Division of Nephrology and Hypertension, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, California, USA.
• ²³ Department of Nephrology, Princess Alexandra Hospital, Brisbane, Australia; Australasian Kidney Trials Network, University of Queensland, Brisbane, Australia; Translational Research Institute, Brisbane, Australia.
• ²⁴ College of Medicine and Public Health, Flinders University, Adelaide, Australia.
• ²⁵ Westmead Institute for Medical Research, The University of Sydney, Sydney, Australia; Sydney Medical School, The University of Sydney, Sydney, Australia.
• ²⁶ Department of Nephrology, Monash Health, Victoria, Australia; Department of Medicine, Monash University, Victoria, Australia.
• ²⁷ Department of Nephrology, Princess Alexandra Hospital, Brisbane, Australia; Australasian Kidney Trials Network, University of Queensland, Brisbane, Australia.
• ²⁸ Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong, China.
• ²⁹ Department of Nephrology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.